Stock comparison
JEENA SIKHO LIFECARE
JSLL.NS$71.33BHealthcare Market cap, Sector
West Pharmaceutical Services
WST$25.38BHealthcare Market cap, Sector
Overall winner
JEENA SIKHO LIFECARE
JSLL.NS 61 WST
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
JSLL.NS6wins
1winsWST
84B
D58
87A
A88
92A
D47
66C
F24
75B
C60
91A
C60
95A
D54
Side-by-side metrics
| Metric | JSLL.NS | WST |
|---|---|---|
| Market cap | Winner: $71.33B | $25.38B |
| P/E (TTM) | Winner: 33.3x | 39.8x |
| EV/EBIT | Winner: 24.1x | 34.0x |
| ROIC (TTM) | Winner: 39.15% | 15.24% |
| Gross margin | Winner: 88.58% | 36.24% |
| Net margin | Winner: 27.68% | 16.85% |
| Revenue CAGR 5y | Winner: 57.81% | 2.08% |
| EPS CAGR 5y | Winner: 86.67% | -6.4% |
| Debt / Equity | 0.3x | 0.1x Winner |
| Dividend yield | - | 0.29% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
JSLL.NS leads on
- EPS CAGR 5y86.67%vs -6.4%+107%
- Revenue CAGR 5y57.81%vs 2.08%+96%
- Market cap$71.33Bvs $25.38B+64%
- ROIC (TTM)39.15%vs 15.24%+61%
WST leads on
- Debt / Equity0.1xvs 0.3x+61%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.